THE IN VITRO CELL CULTURE MODEL OPTIMISATION FOR STUDY OF ENERGY METABOLISM IN HUNTINGTON'S DISEASE

被引:0
|
作者
Krzyszton-Russjan, J. [1 ]
Sitarz, K. [1 ]
Anuszewska, E. L. [1 ]
机构
[1] Natl Med Inst, PL-00725 Warsaw, Poland
关键词
D O I
10.1136/jnnp-2014-309032.64
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
B36
引用
收藏
页码:A21 / A22
页数:2
相关论文
共 50 条
  • [21] Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease
    Buren, Caodu
    Parsons, Matthew P.
    Smith-Dijak, Amy
    Raymond, Lynn A.
    NEUROBIOLOGY OF DISEASE, 2016, 87 : 80 - 90
  • [22] Properties of polyglutamine expansion in vitro and in a cellular model for Huntington's disease
    Lunkes, A
    Trottier, Y
    Fagart, J
    Schultz, P
    Zeder-Lutz, G
    Moras, D
    Mandel, JL
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1999, 354 (1386) : 1013 - 1019
  • [23] Choosing an animal model for the study of Huntington's disease
    Pouladi, Mahmoud A.
    Morton, A. Jennifer
    Hayden, Michael R.
    NATURE REVIEWS NEUROSCIENCE, 2013, 14 (10) : 708 - 721
  • [24] Choosing an animal model for the study of Huntington's disease
    Mahmoud A. Pouladi
    A. Jennifer Morton
    Michael R. Hayden
    Nature Reviews Neuroscience, 2013, 14 : 708 - 721
  • [25] Neuroprotective effect of neural stem cell-conditioned media in in vitro model of Huntington's disease
    Lim, Heon-Chang
    Lee, Soon-Tae
    Chu, Kon
    Joo, Kyung Min
    Kang, Lami
    Im, Woo-Seok
    Park, Joung-Eun
    Kim, Seung U.
    Kim, Manho
    Cha, Choong-Ik
    NEUROSCIENCE LETTERS, 2008, 435 (03) : 175 - 180
  • [26] Energy metabolism defects in Huntington's disease and effects of coenzyme Q(10)
    Koroshetz, WJ
    Jenkins, BG
    Rosen, BR
    Beal, MF
    ANNALS OF NEUROLOGY, 1997, 41 (02) : 160 - 165
  • [27] MIR-122 DYSREGULATION IN SIRNA-TREATED IN VITRO CELL MODEL OF HUNTINGTON'S DISEASE
    Tunali, Nagehan Ersoy
    Keske, Ezgi
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 : A24 - A24
  • [28] Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington's disease
    Chen, Ching-Ya
    Chou, Fang-Yi
    Chang, Ya-Gin
    Ho, Chin-Jui
    Wu, Kuo-Chen
    Hsu, Chia-Lin
    Chern, Yijuang
    Lin, Chun-Jung
    NEUROBIOLOGY OF DISEASE, 2023, 177
  • [29] ESTABLISHING A NEURAL PROGENITOR CELL MODEL OF HUNTINGTON'S DISEASE
    Smith, Edward
    Sathasivam, Kirupa
    Bates, Gillian
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A25 - A26
  • [30] Cell Reprogramming to Model Huntington's Disease: A Comprehensive Review
    Monk, Ruth
    Connor, Bronwen
    CELLS, 2021, 10 (07)